Heart views : the official journal of the Gulf Heart Association · 2025
Characteristics and Outcomes of Heart Failure Outpatients with Improvement in Ejection Fraction in Qatar.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kaddoura Rasha, Shah Jassim Zaheen, Ibrahim Mohamed Izham Mohamed, Singh Rajvir, Chapra Ammar, Alsadi Haisam, Amri Maha Al, Hamamyh Tahseen, Fallouh Manar, Elasad Farras, Abdelghani Mohamed Salah, Alyafei Sumaya Alsaadi, Badr Amr, Patel Ashfaq
Аннотация
INTRODUCTION: Heart failure with reduced ejection fraction (HFrEF) in Qatar has not been well characterized in the outpatient setting.
OBJECTIVE: To describe the characteristics of patients with HFrEF who had improvement in their left ventricular ejection fraction (LVEF) and independent predictors of improvement.
METHODS: This retrospective cohort study conducted at the advanced heart failure (HF) clinic in Qatar recruited patients who visited the clinic between January 2017 and December 2018. Adult patients were eligible if they were diagnosed with HFrEF (LVEF < 40%) and had two echocardiograms separated by at least 6 months.
RESULTS: Of 582 eligible patients, 161 (27.7%) had improved LVEF. They were younger (53.4 vs. 57.3 years, P = 0.002) and had shorter duration of HF diagnosis (4.3 vs. 5.6 years, P = 0.001). They experienced lower rates of all-cause hospitalization (20.5% vs. 38.0%, P = 0.001) and emergency department visits (25.5% vs. 35.9%, P = 0.001), without a difference in hospital mortality rate, than those without LVEF improvement. Decreased odds ratio of improved LVEF was associated with per year increase in age (adjusted odds ratio [aOR]: 0.98, 95% confidence interval [CI]: 0.97-0.99, P = 0.03), presence of left bundle branch block (aOR: 0.40, 95% CI: 0.20-0.80, P = 0.001), duration of HF diagnosis (aOR: 0.85, 95% CI: 0.78-0.94, P = 0.001), and ischemic HF etiology (aOR: 0.50, 95% CI: 0.30-0.77, P = 0.001; compared with dilated etiology). Beta-blocker therapy was associated with higher odds of LVEF improvement (aOR: 2.65, 95% CI: 1.02-6.88, P = 0.001).
CONCLUSION: Patients with HFrEF with improved LVEF were younger, had a nonischemic cardiomyopathy, and had significantly fewer hospitalizations and emergency department visits.
OBJECTIVE: To describe the characteristics of patients with HFrEF who had improvement in their left ventricular ejection fraction (LVEF) and independent predictors of improvement.
METHODS: This retrospective cohort study conducted at the advanced heart failure (HF) clinic in Qatar recruited patients who visited the clinic between January 2017 and December 2018. Adult patients were eligible if they were diagnosed with HFrEF (LVEF < 40%) and had two echocardiograms separated by at least 6 months.
RESULTS: Of 582 eligible patients, 161 (27.7%) had improved LVEF. They were younger (53.4 vs. 57.3 years, P = 0.002) and had shorter duration of HF diagnosis (4.3 vs. 5.6 years, P = 0.001). They experienced lower rates of all-cause hospitalization (20.5% vs. 38.0%, P = 0.001) and emergency department visits (25.5% vs. 35.9%, P = 0.001), without a difference in hospital mortality rate, than those without LVEF improvement. Decreased odds ratio of improved LVEF was associated with per year increase in age (adjusted odds ratio [aOR]: 0.98, 95% confidence interval [CI]: 0.97-0.99, P = 0.03), presence of left bundle branch block (aOR: 0.40, 95% CI: 0.20-0.80, P = 0.001), duration of HF diagnosis (aOR: 0.85, 95% CI: 0.78-0.94, P = 0.001), and ischemic HF etiology (aOR: 0.50, 95% CI: 0.30-0.77, P = 0.001; compared with dilated etiology). Beta-blocker therapy was associated with higher odds of LVEF improvement (aOR: 2.65, 95% CI: 1.02-6.88, P = 0.001).
CONCLUSION: Patients with HFrEF with improved LVEF were younger, had a nonischemic cardiomyopathy, and had significantly fewer hospitalizations and emergency department visits.